A team of U.S. and Chinese researchers appears to have unlocked a novel way to stop T-cells from attacking the…
Articles by Marisa Wexler, MS
Anti-CD20 therapies, a type of treatment approved for multiple sclerosis (MS), alter the activity of several types of immune…
A new imaging technology may help detect early signs of brain damage in people with multiple sclerosis (MS) that…
More than 90% of relapsing-remitting multiple sclerosis (RRMS) patients who received Immunic Therapeutics‘ experimental oral therapy vidofludimus…
A CAR T-cell therapy from Iaso Biotherapeutics was tolerated well and led to marked improvements in disability for three…
In people with benign relapsing-remitting multiple sclerosis (RRMS) who have minimal disease activity, there is a loss of overall…
Hormone therapies used in gender-affirming care for transgender people may affect disease activity in multiple sclerosis (MS), a small…
Children with pediatric-onset multiple sclerosis (POMS) experience biological aging at a faster rate than children without the disease, a…
Infections and stressful life events in childhood may increase the risk of developing multiple sclerosis (MS), while childhood exercise…
Pro-inflammatory signaling molecules that have been implicated in multiple sclerosis (MS) cause problems with the growth and development of…
People who experience adversity during childhood, such as abuse or neglect, may be at increased risk of multiple sclerosis…
The Epstein-Barr virus (EBV) — a well-established risk factor for multiple sclerosis (MS) — is able to alter…
Tysabri (natalizumab), an approved treatment for forms of multiple sclerosis (MS), can be safely used during pregnancy or…
Treatment with masitinib, an experimental therapy being developed by AB Science for progressive forms of multiple sclerosis (MS),…
Quantum Biopharma intends to ask the U.S. Food and Drug Administration (FDA) this year for permission to start a…
Elevated levels of two bacterial strains from the Lachnospiraceae family in the gut may be a key risk factor for…
The U.S. Food and Drug Administration (FDA) has approved a new generic form of glatiramer acetate injection, a treatment for…
In people with relapsing forms of multiple sclerosis (MS) treated with Ocrevus (ocrelizumab), levels of B-cells can help…
People with multiple sclerosis (MS) who experience progression independent of relapse activity (PIRA) tend to have greater damage to…
Foralumab was well tolerated in people with nonactive secondary progressive multiple sclerosis (SPMS), according to data from a small,…
Certain lesions in the spinal cords of people with multiple sclerosis (MS) show damage to nerve fibers despite having…
Wider rims of immune cells surrounding multiple sclerosis (MS) lesions in the brain and spinal cord are associated with…
A new machine learning tool, a form of artificial intelligence (AI), may accurately detect the transition from relapsing-remitting multiple…
New diagnostic criteria and biomarkers, how to manage MS in older patients and children, and vaccine recommendations are among topics…
Assessing multiple sclerosis (MS) disease activity using Octave Bioscience’s MS Disease Activity (MSDA) blood biomarker test can help guide…
Some exercises are better than others at easing certain problems associated with balance in people with multiple sclerosis (MS),…
People with multiple sclerosis (MS) who live in rural areas are 17% less likely to receive disease-modifying therapies…
Sanofi‘s oral BTK inhibitor tolebrutinib significantly delayed the onset of six-month confirmed disability progression compared with a placebo,…
A new artificial intelligence (AI) tool called MindGlide can accurately calculate, from a single MRI scan, multiple aspects of brain…
The patient support program Cycle Vita, which assists patients throughout the process of medical prescriptions, is now available for…